Preservative-free treatment in glaucoma: who, when, and why?

被引:35
|
作者
Stalmans, Ingeborg [1 ]
Megevand, Gordana Sunaric [2 ]
Cordeiro, M. Francesca [3 ]
Hommer, Anton [4 ]
Rossetti, Luca [5 ]
Goni, Francisco [6 ]
Heijl, Anders [7 ]
Bron, Alain [8 ]
机构
[1] Katholieke Univ Leuven Hosp, Dept Ophthalmol, B-3000 Louvain, Belgium
[2] Rothschild Mem, Geneva, Switzerland
[3] Western Eye Hosp, London, England
[4] Hera Hosp, Vienna, Austria
[5] Univ Milan, San Paolo Hosp, Eye Clin, Milan, Italy
[6] SIOVO, Barcelona, Spain
[7] Lund Univ, Dept Ophthalmol, Skane Univ Hosp, Malmo, Sweden
[8] Univ Hosp, Dept Ophthalmol, Dijon, France
关键词
Glaucoma; Intraocular pressure-lowering agents; Ocular surface; Preservative; OCULAR SURFACE DISEASE; TOPICAL ANTIGLAUCOMA MEDICATION; QUALITY-OF-LIFE; BENZALKONIUM CHLORIDE; DRY EYE; BETA-BLOCKER; TEAR FILM; CORNEAL; DRUGS; PREVALENCE;
D O I
10.5301/ejo.5000270
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose: To review and summarize the available literature on the effect of preservatives on the eye, to provide practical guidance for the clinical assessment of the ocular surface in glaucoma patients, and to define patient populations that might benefit from preservative-free topical intraocular pressure (IOP)-lowering agents. Methods: This manuscript is based on a combination of a literature review on preservatives and the eye and expert opinion from glaucoma specialists with an interest in ocular surface disease. Results: There is an increasingly recognized association between eyedrop preservatives and ocular surface disease. Preservative-free therapy is now available for a wide range of active compounds, although there are still some misconceptions regarding their appropriate use. For patients treated topically for glaucoma or ocular hypertension, a rough estimate could be that 20% may need treatment with topical IOP-reducing agents that are free from preservatives. Conclusions: This review provides an up-to-date account of the literature regarding preservatives and the eye, as well as suggestions and recommendations on to when to use preservative-free antiglaucoma treatment.
引用
收藏
页码:518 / 525
页数:8
相关论文
共 50 条
  • [1] Glaucoma therapy: preservative-free for all?
    Thygesen, John
    CLINICAL OPHTHALMOLOGY, 2018, 12 : 707 - 717
  • [2] Preservative-free tafluprost 0.0015% in the treatment of patients with glaucoma and ocular hypertension
    Carl Erb
    Ines Lanzl
    Seid-Fatima Seidova
    Friedemann Kimmich
    Advances in Therapy, 2011, 28
  • [3] Preservative-free tafluprost in the treatment of naive patients with glaucoma and ocular hypertension
    Lanzl, Ines
    Hamacher, Thomas
    Rosbach, Klaus
    Ramez, Mohammed Osman
    Rothe, Robert
    Ruzickova, Eva
    Karhanova, Marta
    Kimmich, Friedemann
    CLINICAL OPHTHALMOLOGY, 2013, 7 : 901 - 909
  • [4] Preservative-free tafluprost in the treatment of naive patients with glaucoma and ocular hypertension
    Lanzl, Ines
    Hamacher, Thomas
    Kimmich, Friedemann
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2013, 54 (15)
  • [5] Preservative-free glaucoma treatment. Selection of the correct treatment in 1 min
    Pfennigsdorf, S.
    Eschstruth, P.
    OPHTHALMOLOGE, 2016, 113 (05): : 409 - 415
  • [6] Preservative-free tafluprost 0.0015% in the treatment of patients with glaucoma and ocular hypertension
    Erb, Carl
    Lanzl, Ines
    Seidova, Seid-Fatima
    Kimmich, Friedemann
    ADVANCES IN THERAPY, 2011, 28 (07) : 575 - 585
  • [7] The treatment of glaucoma using topical preservative-free agents: an evaluation of safety and tolerability
    Konstas, Anastasios G.
    Labbe, Antoine
    Katsanos, Andreas
    Meier-Gibbons, Frances
    Irkec, Murat
    Boboridis, Konstadinos G.
    Hollo, Gabor
    Garcia-Feijoo, Julian
    Dutton, Gordon N.
    Baudouin, Christophe
    EXPERT OPINION ON DRUG SAFETY, 2021, 20 (04) : 453 - 466
  • [8] Preservative-free tafluprost/timolol fixed combination: a new opportunity in the treatment of glaucoma
    Konstas, Anastasios G. P.
    Hollo, Gabor
    EXPERT OPINION ON PHARMACOTHERAPY, 2016, 17 (09) : 1271 - 1283
  • [9] BAK to the Future? Preserved and Preservative-Free Topical Glaucoma Medications
    Saeedi, Osamah
    Chen, Victoria
    EYE & CONTACT LENS-SCIENCE AND CLINICAL PRACTICE, 2022, 48 (04): : 139 - 140
  • [10] Ocular symptoms and signs with preserved and preservative-free glaucoma medications
    Jaenen, N.
    Baudouin, C.
    Pouliquen, P.
    Manni, G.
    Figueiredo, A.
    Zeyen, T.
    EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2007, 17 (03) : 341 - 349